Detalhe da pesquisa
1.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Nature;
615(7953): 697-704, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36890230
2.
CRISPR-Mediated Genomic Addition to CPS1 Deficient iPSCs is Insufficient to Restore Nitrogen Homeostasis.
Yale J Biol Med;
94(4): 545-557, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34970092
3.
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.
Nat Commun;
15(1): 1244, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38336975
4.
Antitumor Immune Responses in B2M-Deficient Cancers.
Cancer Immunol Res;
11(12): 1642-1655, 2023 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37801341
5.
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.
Cancer Discov;
13(4): 880-909, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36700848
6.
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
Nat Med;
29(9): 2278-2285, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37592104
7.
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity.
Cancer Discov;
11(3): 714-735, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33318037
8.
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.
Sci Transl Med;
12(565)2020 10 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33055240
9.
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov;
10(8): 1140-1157, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32467343
10.
Autoantibody Landscape in Patients with Advanced Prostate Cancer.
Clin Cancer Res;
26(23): 6204-6214, 2020 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32967941
11.
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Cancer Cell;
38(4): 500-515.e3, 2020 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32916126
12.
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
Clin Cancer Res;
25(3): 1000-1011, 2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30409823
13.
Investigating the functionality of an OCT4-short response element in human induced pluripotent stem cells.
Mol Ther Methods Clin Dev;
3: 16050, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27500178
14.
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells.
Mol Ther Nucleic Acids;
5(11): e394, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27898091
15.
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Cancer Cell;
39(1): 122, 2021 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33306984
16.
Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.
Stem Cells Transl Med;
4(2): 136-45, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25575527
17.
Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.
J Vis Exp;
(93): e52158, 2014 Nov 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25490111
18.
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.
Stem Cell Res Ther;
4(4): 87, 2013 Jul 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23890092
19.
Human skin cells that express stage-specific embryonic antigen 3 associate with dermal tissue regeneration.
Biores Open Access;
1(1): 25-33, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23514702